Home Immunology & Inflammation gp120/CD4 inhibitor Fostemsavir For research use only.

Fostemsavir

Synonyms: BMS-663068, Rukobia

Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.

Fostemsavir Chemical Structure

Fostemsavir Chemical Structure

CAS No. 864953-29-7

Purity & Quality Control

Batch: S722001 DMSO]100 mg/mL]false]Water]Insoluble]false]Ethanol]Insoluble]false Purity: 99.65%
99.65

Fostemsavir Related Products

Biological Activity

Description Fostemsavir (BMS-663068, Rukobia), the phosphonooxymethyl prodrug of BMS626529, is an attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells with EC50 of < 10 nM.
Targets
HIV-1 gp120 [1]
(Cell-free assay)
10 nM(EC50)
In Vivo
In vivo

BMS-663068 is the phosphonooxymethyl prodrug of BMS-626529 designed to increase the solubility of the compound in the gut. BMS-663068 is cleaved by alkaline phosphatase, located on the luminal surface of the small intestine brush border membranes, releasing BMS-626529. Due to its good membrane permeability, BMS-626529 is then rapidly absorbed.[1] BMS-663068 is an orally active inhibitor of HIV-1 attachment.[2]
Animal Research Animal Models C57BL/7 mice, NSG-SGM3-derived HSC-Hu mice
Dosages 20 mg/kg
Administration Oral gavage
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT04648280 Recruiting
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation|ViiV Healthcare|PHPT Foundation|Hospital Universitario 12 de Octubre|Cromsource
 June 30 2022 Phase 1|Phase 2
NCT05220358 Recruiting
HIV-1-infection
Orlando Immunology Center|ViiV Healthcare
 May 1 2022 Phase 4
NCT02805556 Completed
Infection Human Immunodeficiency Virus
ViiV Healthcare|GlaxoSmithKline
 March 15 2016 Phase 1
NCT02508064 Completed
Infection Human Immunodeficiency Virus
ViiV Healthcare|GlaxoSmithKline
 August 3 2015 Phase 1
NCT02362503 Active not recruiting
HIV Infections
ViiV Healthcare
 February 23 2015 Phase 3

Chemical Information & Solubility

Molecular Weight 583.49 Formula

C25H26N7O8P
CAS No. 864953-29-7 SDF --
Smiles COC1=CN=C([N]2C=NC(=N2)C)C3=C1C(=C[N]3CO[P](O)(O)=O)C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 100 mg/mL ( (171.38 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Fostemsavir | Fostemsavir supplier | purchase Fostemsavir | Fostemsavir cost | Fostemsavir manufacturer | order Fostemsavir | Fostemsavir distributor